• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

I7G:GR

42.740 EUR 0.415 0.96%

As of 15:18:52 ET on 12/23/2014.

Snapshot for Ipsen SA (I7G)

Open: 42.575 Day's Range: 42.575 - 43.094 Volume: 0
Previous Close: 43.155 52wk Range: 28.400 - 43.290 1-Yr Rtn: +31.86%

Stock Chart for I7G

No chart data available.
  • I7G:GR 43.094
  • 1D
  • 1M
  • 1Y
43.155
Interactive I7G Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for I7G

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.2783
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.2170
Est. PEG Ratio 1.6241
Market Cap (M EUR) 3,540.62
Shares Outstanding (M) 82.84
30 Day Average Volume 31
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.87%
Cash Dividend (EUR) 0.8000
Dividend Ex-Date 06/09/2014
5 Year Dividend Growth 2.71%
Next Earnings Announcement 02/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for I7G

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for I7G

Ipsen SA manufactures and markets a wide range of medical drugs for targeted disease areas including oncology, endocrinology, and neuromuscular disorders.

Marc De GaridelChairman/CEOChristel BoriesDeputy CEO
Aymeric Le ChatelierExec VP/CFONathalie JoannesExec VP/General Counsel
More Company Profile & Key Executives for I7G

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil